• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Henry Ford Health System first in U.S. to offer next generation deep brain stimulation

Bioengineer by Bioengineer
February 18, 2021
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Henry Ford Health System

DETROIT (Feb. 18, 2021) – The Parkinson’s Disease and Movement Disorder Center at Henry Ford Health System was the first in the United States to offer a new FDA-approved device to help treat the symptoms of Parkinson’s disease. Neurosurgeon Jason Schwalb, M.D. surgically implanted the Vercise Genus™ Deep Brain Stimulation (DBS) System, which stimulates a targeted region of the brain through – implanted leads that are placed in the brain. The leads are powered by a device called an implantable pulse generator, which sits under the skin in the chest. The case was performed at Henry Ford West Bloomfield Hospital.

Over the past 25 years, more than 160,000 DBS systems have been surgically implanted in patients worldwide to help treat movement disorders, such as Parkinson’s Disease. The Vercise Genus DBS system, which is the fourth generation of the platform and received FDA approval in January 2021, is small and thin, and allows patients to safely undergo MRI scans, when certain conditions are met.

Parkinson’s disease is a progressive neurological condition that affects nearly one million people in the U.S. and 10 million people worldwide. It is the second most common neurodegenerative condition after Alzheimer’s disease. Most people who are diagnosed with Parkinson’s disease are aged 60 or older, and the condition more commonly affects men than women. The first line of treatment for people with Parkinson’s disease is medication, however, medication alone may not always be effective for some patients. To help improve quality of life, in some cases, physicians will consider treatments beyond medication, such as DBS.

“With neurodegenerative movement disorders like Parkinson’s disease, the ability to deliver the right dose of stimulation where it is needed can make a remarkable difference in controlling an individual patient’s symptoms,” said Dr. Schwalb. “This new Deep Brain Stimulation system has the ability to adapt therapy to address fluctuations in symptoms and the progressive nature of the condition, which allows us to control stimulation precisely and minimize unwanted side effects.”

When Vercise Genus DBS System is turned on, the implanted pulse generator sends a pre-determined program of mild electrical impulses to stimulate the brain. Unlike traditional DBS systems that are built from pacemaker technology, the Vercise Genus DBS System technology is developed from a foundation of cochlear implant technology and the precise stimulation of auditory nerves it uses to replicate hearing.

The Vercise Genus DBS System is equipped with Bluetooth® connectivity to provide enhanced communication during programming. The System’s proprietary Cartesia3D provides physicians and patients the precise control of stimulation they need to optimize therapy, and the ability to deliver the prescribed amount of therapy to target different regions of the brain, which can help address changes in symptoms during the progression of the condition.

###

To learn more or request an appointment with appointment with a Parkinson’s disease specialist at Henry Ford, visit henryford.com/ParkinsonsDisease.

About Henry Ford Health System

Founded in 1915 by Henry Ford himself, Henry Ford Health System is a non-profit, integrated health system committed to improving people’s lives through excellence in the science and art of healthcare and healing. Henry Ford Health System includes Henry Ford Medical Group, with more than 1,900 physicians and researchers practicing in more than 50 specialties at locations throughout Southeast and Central Michigan. Acute care hospitals include Henry Ford Hospital in Detroit, MI and Henry Ford Allegiance Health in Jackson, MI – both Magnet® hospitals; Henry Ford Macomb Hospital; Henry Ford West Bloomfield Hospital; and Henry Ford Wyandotte Hospital.

The largest of these is Henry Ford Hospital in Detroit, a quaternary care research and teaching hospital and Level 1 Trauma Center recognized for clinical excellence in cardiology, cardiovascular surgery, neurology, neurosurgery, and multi-organ transplants. The health system also provides comprehensive, best-in-class care for cancer at the Brigitte Harris Cancer Pavilion, and orthopedics and sports medicine at the William Clay Ford Center for Athletic Medicine – both in Detroit.

As one of the nation’s leading academic medical centers, Henry Ford Health System annually trains more than 3,000 medical students, residents, and fellows in more than 50 accredited programs, and has trained nearly 40% of the state’s physicians. Our dedication to education and research is supported by nearly $100 million in annual grants from the National Institutes of Health and other public and private foundations.

Our not-for-profit health plan, Health Alliance Plan (HAP) provides health coverage for more than 540,000 people.

Henry Ford Health System employs more than 33,000 people, including more than 1,600 physicians, more than 6,600 nurses and 5,000 allied health professionals.

Media Contact
Jeff Adkins
[email protected]

Original Source

https://www.henryford.com/news/2021/02/dbs-for-parkinsons

Tags: Health Care Systems/ServicesHealth ProfessionalsMedicine/HealthneurobiologyParkinson
Share13Tweet8Share2ShareShareShare2

Related Posts

ChatGPT’s Potential in Stated-Calorie Diet Planning

ChatGPT’s Potential in Stated-Calorie Diet Planning

July 8, 2025
blank

Microbiome Cell-Free RNA Differentiates Colorectal Cancer

July 8, 2025

Evolving Deaminase Hotspots for Precise Cytosine Editing

July 7, 2025

Linking Body, Behavior to Atherogenic Risk Ratio

July 5, 2025
Please login to join discussion

POPULAR NEWS

  • Zheng-Rong Lu

    Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    75 shares
    Share 30 Tweet 19
  • Enhancing Broiler Growth: Mannanase Boosts Performance with Reduced Soy and Energy

    72 shares
    Share 29 Tweet 18
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    69 shares
    Share 28 Tweet 17
  • New Organic Photoredox Catalysis System Boosts Efficiency, Drawing Inspiration from Photosynthesis

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

ChatGPT’s Potential in Stated-Calorie Diet Planning

Key Amino Acid Changes Attenuate Yellow Fever Vaccine

Giardia Triggers Type 2 Immunity That Reduces Gut Inflammation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.